
Dodla Dairy Q1 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Revenue growth for FY’25 is expected to be around 10%, driven by a mix of value-added products, price increases, and product mix changes.
- Sales volume growth is currently modest at about 2.5% for milk but higher at 6.3% for curd; overall volume growth is expected to remain steady with opportunities in curd and value-added products.
- EBITDA and PAT are both projected to grow in the range of 18% to 20% year-on-year for FY’25.
- Value-added product contribution is targeted to remain around 33%-35% with margins of 12%-13%; plain liquid milk margins are estimated at 7%-8%.
- International business (Africa) aims for 10%-15% sustainable revenue growth.
- Capacity expansions, including new plants (e.g., Kenya and Orgafeed), support growth prospects.
- Strategic pricing and improved milk procurement efficiencies aim to sustain robust volume growth amidst industry competition.
See what Dodla Dairy management said on margin guidance — free account, 30 seconds.
Fundraise plans
- The company has taken a project loan to finance the Orgafeed expansion, which has increased finance costs in Q1 FY25 (Page 4).
- There is no mention of any new or future fundraising through debt or equity in the current or upcoming financial year.
- The management noted that the major capex for the Kenya plant acquisition and expansion is already done and only minor maintenance capex is planned for the coming year (Page 13).
- No specific plans for additional fund raising were discussed during the call.
See what Dodla Dairy management said on order book — free account, 30 seconds.
Capex plans
Yes- Capex for the international business, particularly in Kenya, was largely completed last year with the acquisition of a plant that commenced production in January FY25.
- No significant new capex planned for the coming year in the international business; only minor maintenance capex expected.
- Expansion in the Orgafeed business included a bigger feed plant that began operations last year; current utilization is below optimal but expected to reach 60-65% by FY26.
- Overall, capex focus appears on maintenance and optimizations rather than major new investments in the immediate future.
- Strategic emphasis remains on growing the farmers' network, improving procurement efficiency, and expanding product reach rather than large capital expenditure.
Track Dodla Dairy — get its next earnings analysis in your feed
How does Dodla Dairy rank vs peers in Food Products?
Pro featureHow does Dodla Dairy rank in Food Products?
Compare Dodla Dairy against every Food Products company (Q1 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Dodla Dairy's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Food Products this season
- Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.